| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Jun 4, 2025 | NovoCure Ltd | Director | Sell | 46.3 | -999 | -15.16% | ✗ | $17.2K |
| Jun 15, 2023 | Jun 20, 2023 | SI-BONE, Inc. | Director | Sell | 15.0 | -4,162 | -21.33% | ✓ | $118.1K |
| Jun 10, 2022 | Jun 16, 2022 | NovoCure Ltd | Director | Sell | 28.8 | -407 | -13.82% | ✓ | $28.3K |
| Jun 13, 2022 | Jun 14, 2022 | SI-BONE, Inc. | Director | Sell | 18.8 | -1,924 | -23.34% | ✓ | $26.6K |
| Jun 25, 2021 | Jun 28, 2021 | SI-BONE, Inc. | Director | Sell | 10.0 | -4,400 | -34.80% | ✓ | $148.3K |
| Jun 9, 2021 | Jun 11, 2021 | NovoCure Ltd | Director | Sell | 30.0 | -456 | -5.99% | ✓ | $266.7K |
| Dec 18, 2020 | Dec 22, 2020 | NovoCure Ltd | Director | Sell | 7.5 | -2,500 | -42.37% | ✓ | $416K |
| Jun 26, 2019 | Jun 27, 2019 | Minerva Neurosciences, Inc. | Director | Buy | 90.0 | +1,000 | 100.00% | ✗ | $5.3K |